Powered by Q1Group LLC
Education and Decision Support Tools for the Medicare Community


June 2018 summary of the new medications added to Medicare Part D plan formularies (drug lists)

Category: Monthly Formulary Changes
Published on 2018-06-19 18:42:25


The June, 2018 Medicare Part D plan formulary data (or drug lists) includes the addition of 52 new National Drug Codes (NDCs) to the Medicare Part D program.  These NDCs represent 33 different drugs, many with multiple strengths.

New Generic Drugs Introduced
Some highlights of the June formulary updates include four (4) new generic equivalents: Isotretinoin, the generic for Zenatane®, Sodium Phenylbutyrate, the generic for Buphenyl®, Sumatriptan-Naproxen, the generic for Treximet®, and Trientine Hcl, the generic for Syprine®.

New Brand-Name Drugs Introduced
In addition, 12 new brand-name drugs, some with multiple strengths, were added to Medicare Part D plan formularies.  These drugs include, ADZENYS®, BIKTARVY®, DIGOX®, DUZALLO®, DYANAVEL®, ENDARI®, ERLEADA®, NATROBA®, SEGLUROMET®, SYMDEKO®, TAPERDEX®, and TRULANCE®.

What is the NDC?
The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: https://Q1FAQ.com/155.html

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 52 new NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 4
New Delivery Form and Strength 1
New Drug 14
New Drug and Strength 12
New Manufacturer 2
New Manufacturer and Strength 8
New Manufacturer, Strength and Delivery Form
1
New Strength 10
Total New NDCs 52

Reminder: (1) Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan. (2) Your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

The following chart details the first 52 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates. You can click on the Drug Code (NDC) or Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) to see the details of how this drug is covered by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.

NDC Drug Name Notes
31722056224 ABACAVIR 20 MG/ML SOLUTION New Manufacturer, Strength and Delivery Form
70165000315 ADZENYS ER 1.25 MG/ML SUSP BP 24H New Drug
61958250101 BIKTARVY 50-200-25 MG TABLET New Drug
00023611803 CONDYLOX 0.5% GEL New Drug
00527132401 DIGOX 125 MCG TABLET New Drug and Strength
00527132501 DIGOX 250 MCG TABLET New Drug and Strength
70785002230 DUZALLO 200-300 MG TABLET New Drug
27808010201 DYANAVEL XR 2.5 MG/ML SUSP New Drug
64980040709 EFAVIRENZ 200 MG CAPSULE [Sustiva] New Strength
00378223393 EFAVIRENZ 600 MG TABLET [Sustiva] New Manufacturer and Strength
42457042001 ENDARI 5 GRAM POWDER PACKET New Drug
59676060012 ERLEADA 60 MG TABLET New Drug
52246040030 ESOMEPRAZOLE DR 49.3 MG CAP [Nexium] New Manufacturer and Strength
00406920230 FENTANYL CITRATE OTFC 200 MCG [Actiq] New Strength
00406921230 FENTANYL CITRATE OTFC 1,200 MCG [Actiq] New Strength
00406921630 FENTANYL CIT OTFC 1,600 MCG [Actiq] New Strength
00406920430 FENTANYL CITRATE OTFC 400 MCG [Actiq] New Strength
00406920630 FENTANYL CITRATE OTFC 600 MCG [Actiq] New Strength
45802013132 Halobetasol Propionate 0.5mg/g 1 TUBE per CARTON / 50 g in 1 TUBE New Delivery Form
51991093317 HALOPERIDOL LAC 5 MG/ML SYRING New Manufacturer
69238117401 ISOTRETINOIN 10 MG CAPSULE [ZENATANE] New Drug and Strength
69238117501 ISOTRETINOIN 20 MG CAPSULE [ZENATANE] New Drug and Strength
69238101703 ISOTRETINOIN 30 MG CAPSULE [ZENATANE] New Drug and Strength
69238117601 ISOTRETINOIN 40 MG CAPSULE [ZENATANE] New Drug and Strength
00378728485 LEVONO-E ESTRAD 0.10-0.02-0.01 New Strength
65162078303 MEMANTINE HCL ER 14 MG CAPSULE SPR 24 [Namenda] New Manufacturer and Strength
65162078403 MEMANTINE HCL ER 21 MG CAPSULE SPR 24 [Namenda] New Manufacturer and Strength
10370034909 MEMANTINE HCL ER 28 MG CAPSULE SPR 24 [Namenda] New Manufacturer and Strength
65162078203 MEMANTINE HCL ER 7 MG CAPSULE SPR 24 [Namenda] New Manufacturer and Strength
63323012310 METHOTREXATE 250 MG/10 ML VIAL New Manufacturer
00093213356 MINOCYCLINE ER 115 MG TABLET New Manufacturer and Strength
00093213456 MINOCYCLINE ER 65 MG TABLET New Manufacturer and Strength
00409178203 NALOXONE 0.4 MG/ML CARPUJECT New Delivery Form
52246092904 NATROBA 0.9% TOPICAL SUSP New Drug
57893031060 NOLIX 0.05% CREAM New Delivery Form and Strength
70362072030 PANLOR 325-30-16 MG TABLET New Drug
59310030240 QVAR REDIHALER 40 MCG New Delivery Form
59310030480 QVAR REDIHALER 80 MCG New Delivery Form
00006537303 SEGLUROMET 2.5-1,000 MG TABLET New Drug and Strength
00006536906 SEGLUROMET 2.5-500 MG TABLET New Drug and Strength
00006537403 SEGLUROMET 7.5-1,000 MG TABLET New Drug and Strength
00006537003 SEGLUROMET 7.5-500 MG TABLET New Drug and Strength
49884017004 SODIUM PHENYLBUTYRATE 500MG TB [Buphenyl] New Drug
65862092836 SUMATRIPTAN-NAPROXEN 85-500 MG [Treximet] New Drug
51167066101 SYMDEKO 100/150 MG-150 MG TABS New Drug
42195014912 TAPERDEX 12 DAY 1.5 MG TABLET New Drug and Strength
42195012106 TAPERDEX 6 DAY 1.5 MG TABLET New Drug and Strength
70347020002 TOPROL XL 200 MG TABLET ER 24H New Strength
00591491001 TRIENTINE HCL 250 MG CAPSULE [Syprine] New Drug
70194000330 TRULANCE 3 MG TABLET New Drug
00023611601 ZENPEP DR 25,000 UNIT CAPSULE New Strength
00023611501 ZENPEP DR 5,000 UNIT CAPSULE New Strength

Our online Formulary Browser and Drug Finder
You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.






Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs




Find Your Prescription Discount
Prescription Discounts are
easy as 1-2-3
  1. Locate lowest price drug and pharmacy
  2. Show card at pharmacy
  3. Get instant savings!
Your drug discount card is available to you at no cost.




Tips & Disclaimers
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDP-Compare.com and MA-Compare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.